We use cookies to improve your experience. By your continued use of this site you accept such use.
CPHI Middle East

  • Multimedia content

  • Images (3)
    • Stage set for international collaboration upscaling and regional market entries while health and environmental interplay come under the microscope
    • CPHI Middle East Attracts Global Hub Players as Region Advances BioTech and Pharma Capabilities
    • Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma convention in the region
  • All (3)
Source: CPHI Middle East |

CPHI Middle East Attracts Global Hub Players as Region Advances BioTech and Pharma Capabilities

Industry experts, influencers, and pioneers from the world’s top pharmaceutical hubs will gather at the inaugural CPHI Middle East – the most comprehensive pharma convention in the region

Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma convention in the region Stage set for international collaboration, upscaling, and regional market entries, while health and environmental interplay come under the microscope Industry trailblazers from over 100 nations across Africa,…

U.S. Embassy and Consulate in Nigeria
Source: U.S. Embassy and Consulate in Nigeria |

United States Agency for International Development (USAID) Announces $2.3 Million Commitment to Procure Life-Saving Malaria Tablets from Swiss Pharma

According to the World Health Organization (WHO), fewer than 10% of medicines manufactured in sub-Saharan Africa meet global standards, limiting local companies’ ability to supply essential drugs and meet healthcare needs

The U.S. Agency for International Development (USAID) has committed $2.3 million to procure 4.8 million doses of life-saving malaria tablets from Swiss Pharma (Swipha) in a landmark partnership that will expand access to essential medicines in Nigeria and West Africa. This procurement, to be facilitated through the U.S. Government’s President’s…

World Health Organization (WHO) - Ethiopia
Source: World Health Organization (WHO) - Ethiopia |

Five regions in Ethiopia conducted- Polio vaccination with novel oral polio vaccine (nOPV2) vaccine to reach over 5.6 million children

This first round nOPV2 campaign was carried out efficiently in all the target woredas

Ethiopia conducted a polio vaccination campaign in five regions (Afar, Amhara, Gambella, Addis Ababa, and Sheger City of Oromia Region) with type 2 novel oral polio vaccine (nOPV2) targeting over 5.6 million aged below five years aiming to prevent transmission & circulation of variant poliovirus outbreaks. The campaign was officially…

Pfizer

  • Multimedia content

  • Images (2)
    • Pfizer Supplies One Billionth Pneumococcal Conjugated Vaccine Dose for Vaccination of Children in Lower- Income Countries Through Gavi, the Vaccine Alliance (1)
    • Pfizer Supplies One Billionth Pneumococcal Conjugated Vaccine Dose for Vaccination of Children in Lower- Income Countries Through Gavi, the Vaccine Alliance (2)
  • All (2)
Source: Pfizer |

Pfizer Supplies One Billionth Pneumococcal Conjugated Vaccine Dose for Vaccination of Children in Lower- Income Countries Through Gavi, the Vaccine Alliance

The Vaccine Alliance is a public-private partnership that brings together governments, global health organizations, the vaccine industry and other sectors to increase equitable and sustainable access to vaccines

The 1 billionth pneumococcal vaccine dose was delivered to Ethiopia Since 2010, Pfizer pneumococcal vaccines have reached 57 Gavi-eligible countries to help protect an estimated 300 million plus children The collaboration is a part of Pfizer’s commitment to help close the global health equity gap and bring our medicines and…

GITEX Global

  • Multimedia content

  • Images (1)
    • Isabell Gradert, Vice President of Central Research & Technology, Airbus, Germany
  • All (1)
Source: GITEX Global |

GITEX GLOBAL 2024: Artificial Intelligence (AI) revolution unveiled to the world on “AI Super Tuesday”

As AI takes centre stage in drug discovery, the world could soon witness the most significant shift in medicine since the advent of modern pharmaceuticals

International exhibitors presented the most groundbreaking innovations helping shape the future of society and industry “Cybersecurity Day” next up as world’s largest and best-rated tech event reaches halfway stage on Wednesday Hot on the heels of a memorable first day where GITEX GLOBAL 2024 (http://apo-opa.co/4hlR7gj) opened the doors for its biggest-ever…

UN News
Source: UN News |

World Health Organization (WHO) calls for action to halt rise in hearing loss in Africa

Hearing loss already costs the continent $27 million annually, exacting profound impact on lives and economies, according to the report, which was launched at the African Summit on Hearing Impairment in Nairobi, Kenya

The number of people in Africa living with hearing loss could rise to 54 million by 2030, up from 40 million today, unless urgent measures are taken, the World Health Organization (WHO) said in a report published on Monday.  Hearing loss already costs the continent $27 million annually, exacting profound…

Economic Community of West African States (ECOWAS)
Source: Economic Community of West African States (ECOWAS) |

The 2023 West African Epidemiology Network on Drug Use (WENDU) Report: Statistics and Trends on Illicit Drug Supply and Drug Use Officially Released

The Report highlighted the emerging threat of new drugs, particularly Kush, which has created a public health emergency in several Economic Community of West African States (ECOWAS) Member States (MS)

The 2023 West African Epidemiology Network on Drug Use (WENDU) Report: Statistics and Trends on Illicit Drug Supply and Drug Use was officially launched on 11th September 2024 in Freetown, Sierra Leone during a hybrid event that involved both virtual and in-person participants. The meeting aimed to achieve two primary…

EVA Pharma

  • Multimedia content

  • Images (3)
    • EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources
    • EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources (FR)
    • EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources (AR)
  • All (3)
Source: EVA Pharma |

EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources

Under this royalty-free voluntary licensing agreement EVA Pharma will manufacture and supply Lenacapavir active pharmaceutical ingredient and finished pharmaceutical product

EVA Pharma (www.EVAPharma.com) announced today a non-exclusive, royalty-free voluntary licensing agreement signed with Gilead (https://apo-opa.co/4dB3Nwx), allowing EVA Pharma to manufacture and supply generic lenacapavir in form of active pharmaceutical ingredient and finished pharmaceutical product. This agreement includes the technology transfer of know-how to make and use lenacapavir allowing for sustainable accessibility…

Bio-Sourcing
Source: Bio-Sourcing |

Bio-Sourcing secures European Innovation Council (EIC) Accelerator funding to bridge the biomanufacturing gap and make biotherapeutics more available and affordable

The first biosimilar the company will bring to trials is adalimumab (Humira), a widely used treatment for autoimmune diseases

The funding – a €2.5M grant and additional €10M in equity - shows clear recognition of the ability of Bio-Sourcing’s (www.Bio-Sourcing.com) technical platform to impart changes on biomanufacturing sovereignty and to increase access to cutting-edge pharmaceuticals treatments, such as biosimilars; The BioMilk platform allows large volume production with limited capital expenditure…

World Health Organization - Regional Office for the Eastern Mediterranean
Source: World Health Organization - Regional Office for the Eastern Mediterranean |

Childhood Cancer Awareness Month

Children with lived experience with cancer and their families should play a vital part in the design, implementation and follow-up of programmes

Yazan is a 20-year-old Syrian who was diagnosed with Ewing sarcoma as a child. The conflict in Syria and resulting humanitarian crisis meant that Yazan struggled to access treatment for his cancer, and he received little support from his school and community. “I was denied entry to my final exams…